Bibliografía del artículo
1. Blaser MJ. Ecology of Helicobacter pylori in the human stomach. J Clin Invest 100:759-762, 1997.
2. Blaser MJ, Perez-Perez GI, Kleanthous H, et al. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 55:2111-2115, 1995.
3. Ng FH, Lai KC, Wong BC, et al. [13C]-urea breath test without prior fasting and without test meal is accurate for the detection of Helicobacter pylori infection in Chinese. J Gastroenterol Hepatol 17:834-838, 2002.
4. Chang MC, Chang YT, Sun CT, Wu MS, Wang HP, Lin JT. Quantitative correlation of Helicobacter pylori stool antigen (HpSA) test with 13C-urea breath test (13C-UBT) by the updated Sydney grading system of gastritis. Hepatogastroenterology 49:576-579, 2002.
5. Goossens H, Glupczynski Y, Burette A, Van den Borre C, Butzler JP. Evaluation of commercially available second generation immunoglobulin G enzyme immunoassay for detection of Helicobacter pylori infection. J Clin Microbiol 30:176-180, 1992.
6. Brooks HJ, Ahmed D, McConnell MA, Barbezat GO. Diagnosis of Helicobacter pylori infection by polymerase chain reaction: is it worth it? Diagn Microbiol Infect Dis 50:1-5, 2004.
7. Lam SK, Talley NJ: Consensus conference on the management of Helicobacter pylori infection. J Gastroenterol Hepatol 13:1-12, 1998.
8. Marshall BJ. Treatment strategies for Helicobacter pylori infection. Gastrenterol Clin North Am 22:183-198, 1993.
9. Laine L, Estrada R, Trujillo M, Knigge K, Fennerty MB. Effect of proton pump inhibitor therapy on diagnostic testing for Helicobacter pylori. Ann Intern Med 129:547-550, 1998.
10. Dickey W, Kenny BD, McConnell JB. Effect of proton pump inhibitors on the detection of Helicobacter pylori in gastric biopsies. Aliment Pharmacol Ther 10:289-293, 1996.
11. Malfertheiner P, Megraud F, O'Morain C, et al. European Helicobacter Pylori Study Group (EHPSG). Current concepts in the management of Helicobacter pylori Infection: the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther 16:167-80, 2002.
12. Siddiqi S, Hamid S, Rafique G, et al. Prescription practices of public and private health care providers in Attock District of Pakistan. Int J Health Plann Manage 17:23-40, 2002.
13. Sturm AW, van der Pol R, Smits AJ, et al. Over-the-counter availability of antimicrobial agents, self-medication and patterns of resistance in Karachi, Pakistan. J Antimicrob Chemother 39:543-547, 1997.
14. Morio O, Rioux-Leclercq N, Pagenault M, et al. Prospective evaluation of a new rapid urease test (Pronto Dry) for the diagnosis of Helicobacter pylori infection. Gastroenterol Clin Biol 28(6-7 Pt 1):569-573, 2004.
15. Yakoob J, Jafri W, Abid S, et al. Role of rapid urease test and histopathology in the diagnosis of Helicobacter pylori infection in a developing country. BMC Gastroenterol 5:38, 2005.
16. Yakoob J, Jafri W, Abbas Z, Abid S, Islam M, Ahmad Z The diagnostic yield of various tests for Helicobacter pylori infection in patients on acid reducing drugs. Digest Dis Sci 2007, in press.
17. Graham DY, Genta R, Evans DG, et al. Helicobacter pylori does not migrate from the antrum to the corpus in response to omeprazole. Am J Gastroenterol 91:2120-2124, 1996.
18. Kalantar J, Xia HHX, Wyatt JMa, Rose D, Talley NJ. Determination of optimal biopsy sites for detection of H. pylori in patients treated or not treated with antibiotics and anti-secretory drugs. Gastroenterology 112: A165, 1997.
19. Sewell, WCA. Histopathology and cytopathology of limited or no clinical value. 2nd edition, 2005.
20. Said RM, Cheah PL, Chin SC, Goh KL. Evaluation of a new biopsy urease test: Pronto Dry for the diagnosis of Helicobacter pylori infection. Eur J Gastroenterol Hepatol 16:195-199, 2004.
21. Schnell GA, Schubert TT, Barnes WG, Rupani MK. Comparison of urease, H & E and culture tests for Helicobacter pylori. Gastroenterology 94:A 410, 1998.